-+ 0.00%
-+ 0.00%
-+ 0.00%

UPDATE 1-Novo Nordisk's anti-inflammatory drug fails to reduce cardiovascular risk in late-stage trial

路透·07/31/2026 11:47:03

登录查看新闻详情